GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-07-30
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) plus letrozole in obese progestin-insensitive atypical endometrial hyperplasia (EAH) patients.